High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
Jesus Loarce‐Martos, Antía García Fernández, F. López-Gutiérrez, V. García García, Laura Calvo-Sanz, Iván del Bosque-Granero, M. Andreína Terán-Tinedo, Alina Boteanu, Javier Bachiller‐Corral, Mónica Vázquez Díaz
Topics & Concepts
MedicineRituximabInternal medicineRheumatologyPneumoniaDiseaseMortality rateRheumatoid arthritisLymphomaDermatological and COVID-19 studiesCOVID-19 Clinical Research StudiesInflammasome and immune disorders